文献速递血液净化与透析急性肾损伤

住院患者常规避免肝素透析的前瞻性研究

Prospective Study of Routine Heparin Avoidance Hemodialysis in a Tertiary Acute Care Inpatient Practice.
PubMed 文献 · Kidney Int Rep · 2017-03-16

该前瞻性研究评估了急性照护住院患者采用无肝素透析方案(使用无气透析管路)的可行性,共1200次透析、338例患者。结果显示仅4.5%的透析在体外循环中使用肝素,管路凝血率为5.2%,凝血与临时导管和输血相关,而全身抗凝和抗血小板药具有保护作用。凝血事件与较低的Kt/V相关。

要点

  • 无肝素透析方案在住院患者中可行,管路凝血率低(5.2%)。
  • 临时导管和输血是管路凝血的危险因素,全身抗凝和抗血小板药有保护作用。
  • 管路凝血与透析剂量(Kt/V)降低相关,需关注透析效率。

核心结论

  • 采用无气透析管路的无肝素透析方案在急性照护住院患者中可行且安全,管路凝血率低。

研究设计与样本

  • 前瞻性研究,纳入2014年1月17日至2015年5月31日期间需要血液透析的急性照护住院患者338例,共1200次透析。

主要发现

  • 中位透析时长211分钟(IQR 183-240分钟),透析剂量Kt/V为1.4(IQR 1.2-1.7)。
  • 仅4.5%的透析在体外循环中处方肝素,体外循环凝血率为5.2%。
  • 管路凝血的危险因素包括临时导管(OR 2.8,P<0.01)和输血(OR 2.4,P=0.04)。
  • 全身治疗性抗凝(OR 0.2,P<0.01)和抗血小板药(OR 0.4,P<0.01)具有保护作用。
  • 管路凝血与较低的Kt/V相关(差值0.39,P<0.01)。

临床怎么用

  • 在出血风险高的住院患者中,可考虑采用无气透析管路的无肝素透析方案。
  • 使用临时导管或输血时需警惕管路凝血风险,并监测透析效率。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Extracorporeal circuit (EC) anticoagulation with heparin is a key advance in hemodialysis (HD), but anticoagulation is problematic in inpatients at risk of bleeding. We prospectively evaluated a heparin-avoidance HD protocol, clotting of the EC circuit (CEC), impact on dialysis efficiency, and associated risk factors in our acute care inpatients who required HD (January 17, 2014 to May 31, 2015). METHODS: HD sessions without routine EC heparin were performed using airless dialysis tubing. Patients received systemic anticoagulation therapy and/or antiplatelets for non-HD indications. We observed patients for indications of CEC (interrupted HD session, circuit loss, or inability to return blood). The primary outcome was CEC. Logistic regression with generalized estimating equations assessed associations between CEC and other variables. RESULTS: HD sessions (n = 1200) were performed in 338 patients (204 with end-stage renal disease; 134 with acute kidney injury); a median session was 211 minutes (interquartile range [IQR]: 183-240 minutes); delivered dialysis dose measured by Kt/V was 1.4 (IQR: 1.2 Kt/V 1.7). Heparin in the EC was prescribed in only 4.5% of sessions; EC clotting rate was 5.2%. Determinants for CEC were temporary catheters (odds ratio [OR]: 2.8; P < 0.01), transfusions (OR: 2.4; P = 0.04), therapeutic systemic anticoagulation (OR: 0.2; P < 0.01), and antiplatelets (OR: 0.4; P < 0.01). CEC was associated with a lower delivered Kt/V (difference: 0.39; P < 0.01). Most CEC events during transfusions (71%) occurred with administration of blood products through the HD circuit. DISCUSSION: We successfully adopted heparin avoidance using airless HD tubing as our standard inpatient protocol. This protocol is feasible and safe in acute care inpatient HD. CEC rates were low and were associated with temporary HD catheters and transfusions. Antiplatelet agents and systemic anticoagulation were protective.ClinicalTrials.gov Identifier:NCT02086682.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Safadi S, Albright RC, Dillon JJ, et al. Prospective Study of Routine Heparin Avoidance Hemodialysis in a Tertiary Acute Care Inpatient Practice. Kidney Int Rep. 2017. PMID: 29142987. doi:10.1016/j.ekir.2017.03.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。